EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Lexology, finance.biggo.com, STAT and Fierce Pharma. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 3h ago.
Quick answers
Why is "EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources sa" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- The BIOSECURE Act has a long runway, but pharma GCs don’t Lexology · 8h ago
- Moolenaar: US-China Biotech Deals Jumped From $5B to $136B, and Congress Wants Guardrails finance.biggo.com · 8h ago
- Pharmalittle: We're reading about licensing deals with China, making drugs in space, and more STAT · 8h ago
- Fierce Pharma Asia—China deals safe from COINS?; Key WCLC data; Legend’s new CEO Fierce Pharma · 8h ago
- EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say Reuters · 8h ago
Topics
Related trends
Exclusive | Paramount in Advanced Settlement Talks With California’s Attorney General
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Exclusive | Gemini Hacked Three Companies in First Known Breakout by Google’s AI
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
EXCLUSIVE: Converse Responds After Campaign Ad Draws KKK and Lynching Comparisons Online: ‘We’re Sorry’
1 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
The U.S. says China's AI progress is down to 'distillation.' But is it that clear cut?
2 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Exclusive: US military moving drones to South America ahead of anticipated counternarcotics operations
4 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
China vessel rams Philippine boat on refueling mission, coast guard says
9 news sources are covering this World story right now — PULSE is tracking how fast it spreads.